Dr. Gusdon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6400 Fannin St Ste 2800
Houston, TX 77030Phone+1 713-486-8000Fax+1 713-486-8088
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2013 - 2017
- University of Pittsburgh School of MedicineClass of 2013
Certifications & Licensure
- IN State Medical License 2022 - 2025
- TX State Medical License 2019 - 2025
- MD State Medical License 2018 - 2020
- NY State Medical License 2016 - 2018
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Systemic Metabolic Alterations after Aneurysmal Subarachnoid Hemorrhage: A Plasma Metabolomics Approach.Bosco Seong Kyu Yang, Jude P J Savarraj, Hua Chen, Sarah N Hinds, Glenda L Torres
Medrxiv. 2025-01-07 - 1 citationsMetabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage.Bosco Seong Kyu Yang, Spiros L Blackburn, Philip L Lorenzi, Huimahn A Choi, Aaron M Gusdon
Neurotherapeutics. 2025-01-01 - 1 citationsMitochondrial-targeted therapies in traumatic brain injury: From bench to bedside.Sidra Tabassum, Silin Wu, Chang-Hun Lee, Bosco Seong Kyu Yang, Aaron M Gusdon
Neurotherapeutics. 2025-01-01
Press Mentions
- Anti-Inflammatory Compound Shows Promise in Treating Severe COVID-19July 23rd, 2022
- COVID-19 Treatment Hope Found in Anti-Inflammatory DrugJuly 22nd, 2022
- Anti-Inflammatory Compound Shows Potential in Treating Patients with Severe COVID-19July 20th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: